Environmental impact of colorectal cancer screening with colonoscopy and multi-target stool DNA (mt-sDNA) testing

被引:0
|
作者
Alcock, Rebecca [1 ,2 ]
Shaukat, Aasma [3 ]
Kisiel, John B. [4 ]
Hernandez, Lyndon, V [5 ,6 ]
Delarmente, Benjo A. [7 ]
Estes, Chris [1 ]
Bartels, Jeff [1 ]
Lester, Jason [1 ]
Vahdat, Vahab [1 ]
Limburg, Paul J. [1 ]
Fendrick, A. Mark [8 ,9 ]
机构
[1] Exact Sci Corp, Madison, WI 53719 USA
[2] Univ Wisconsin Madison, Dept Ind & Syst Engn, Madison, WI 53706 USA
[3] NYU Grossman Sch Med, Dept Med, Div Gastroenterol, New York, NY 10016 USA
[4] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[5] Med Coll Wisconsin, Div Gastroenterol, Milwaukee, WI 53226 USA
[6] GI Associates, Milwaukee, WI 53215 USA
[7] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, David Geffen Sch Med, UCLA Value Based Care Res Consortium, Los Angeles, CA 90024 USA
[8] Univ Michigan, Div Gen Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[9] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA
来源
HEALTH AFFAIRS SCHOLAR | 2025年 / 3卷 / 03期
关键词
colorectal cancer screening; sustainability; colonoscopy; mt-sDNA; multi-target stool-DNA; environmental impact;
D O I
10.1093/haschl/qxaf041
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The substantial carbon footprint imparted by medical services warrants increased attention to their environmental impact. National guideline organizations such as the US Preventive Services Task Force (USPSTF) recommend multiple modalities for average-risk colorectal cancer (CRC) screening with varying resource intensity. The aim of this study was to quantify the environmental burden for 2 of the most used CRC screening modalities, colonoscopy and the multi-target stool DNA (mt-sDNA) test. A validated CRC microsimulation model was used to estimate the number of screening and follow-up tests for a cohort of 1 million average-risk individuals who underwent screening between ages 45 and 75. Component resources used for mt-sDNA, including waste products, energy, and transportation for colonoscopy and mt-sDNA, were collected from January 1, 2023, to January 1, 2024, and converted to carbon-equivalent emissions. Resources used for colonoscopy were captured from the literature. Resources devoted to screening colonoscopy were substantially (59%) higher than those to mt-sDNA, even when including follow-up colonoscopy. Of note, follow-up colonoscopy accounted for the majority (64%) of total emissions for the mt-sDNA screening strategy. Compared with colonoscopy screening, mt-sDNA substantially reduces the carbon emissions attributable to population-level CRC screening. Environmental impact should be included as a factor when choosing among guideline-recommended CRC screening strategies. The health care sector is responsible for over 4% of the global carbon footprint. The environmental impact can be reduced by prioritizing lower-carbon options when there are multiple choices available, as with average-risk colorectal cancer (CRC) screening. We used modeling to compare the impact of 2 commonly used CRC screening methods: colonoscopy and the multi-target stool DNA (mt-sDNA) test. Resource use was calculated, including waste and energy consumption from screening, patient travel, and test kit shipping. The estimated carbon-equivalent emissions for screening colonoscopy were 59% higher than for mt-sDNA, and most emissions from mt-sDNA were from follow-up colonoscopy after a positive test result. The reduced environmental impact of mt-sDNA screening as compared with colonoscopy is 1 factor that can be considered when choosing among guideline-recommended CRC screening options. The environmental impact of colorectal cancer screening with noninvasive multi-target stool DNA (mt-sDNA) was compared with colonoscopy. There were 59% more carbon-equivalent emissions with a colonoscopy screening strategy as compared with mt-sDNA. Most emissions incurred by the mt-sDNA strategy were attributable to follow-up colonoscopy after a positive mt-sDNA result. The results demonstrate that the environmental impact of colorectal cancer screening varies significantly across guideline-endorsed options. Environmental considerations could serve as an additional criterion for patients choosing a screening modality.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Multi-Target Stool DNA Testing: High Positive Predictive Value Among Average Risk Patients New to Colorectal Cancer Screening
    Eckmann, Jason D.
    Ebner, Derek
    Bering, Jamie
    Kahn, Allon
    Rodriguez, Eduardo A.
    Devens, Mary
    Lowrie, Kari
    Doering, Karen A.
    Then, Sara
    Burger, Kelli
    Mahoney, Doug
    Ahlquist, David A.
    Prichard, David
    Wallace, Michael
    Gurudu, Suryakanth R.
    Kisiel, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S161 - S162
  • [32] Application of the Colorectal Cancer (CRC) Screening Guiding Principles for Non-invasive Testing to Multi-target Stool DNA: A Case Study
    Melson, Joshua
    DIGESTIVE DISEASES AND SCIENCES, 2025,
  • [33] Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study
    Imperiale, Thomas F.
    Lavin, Philip T.
    Marti, Tara N.
    Jakubowski, Debbie
    Itzkowitz, Steven H.
    May, Folasade P.
    Limburg, Paul J.
    Sweetser, Seth
    Daghestani, Anas
    Berger, Barry M.
    CANCER PREVENTION RESEARCH, 2023, 16 (02) : 89 - 97
  • [34] Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population
    Shepherd, Martha E.
    Lecorps, Ashlee
    Harris-Shapiro, Jon
    Miller-Wilson, Lesley-Ann
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2021, 12
  • [35] The Utility of Multitarget Stool DNA Testing for Colorectal Cancer Screening After a Normal Colonoscopy
    Rao, Abhinav K.
    Kalra, Shivam
    Van Leer-Greenberg, Brett
    Rockey, Don C.
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [36] Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA
    Ebner, Derek W.
    Eckmann, Jason D.
    Burger, Kelli N.
    Mahoney, Douglas W.
    Bering, Jamie
    Kahn, Allon
    Rodriguez, Eduardo A.
    Prichard, David O.
    Wallace, Michael B.
    Kane, Sunanda, V
    Rutten, Lila J. Finney
    Gurudu, Suryakanth R.
    Kisiel, John B.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (06) : E00375
  • [37] CROSS-SECTIONAL ADHERENCE WITH THE MULTI-TARGET STOOL DNA TEST FOR COLORECTAL CANCER SCREENING IN A MEDICAID POPULATION
    Miller-Wilson, L. A.
    Rutten, Finney L. J.
    Van Thomme, J.
    Ozbay, A. B.
    Limburg, P. J.
    VALUE IN HEALTH, 2021, 24 : S127 - S127
  • [38] Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population
    Miller-Wilson, Lesley-Ann
    Rutten, Lila J. Finney
    Van Thomme, Jack
    Ozbay, A. Burak
    Laffin, Jennifer
    Limburg, Paul
    PREVENTIVE MEDICINE REPORTS, 2022, 30
  • [39] COST EFFECTIVENESS OF MULTI-TARGET STOOL DNA TEST VERSUS COLONOSCOPY OR FECAL IMMUNOCHEMICAL TEST FOR COLORECTAL CANCER SCREENING AMONG ALASKA NATIVE PEOPLE
    Redwood, Diana
    Dinh, Anh-Tuan
    Kisiel, John B.
    Borah, Bijan
    Moriarty, James
    Provost, Ellen
    Sacco, Frank
    Tiesinga, James
    Ahlquist, David A.
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB446 - AB447
  • [40] Cost-Effectiveness of Mt-sDNA vs Fecal Immunochemical Test for Colorectal Cancer Screening in a Medicare Population
    Ebner, Derek W.
    Kisiel, John
    Vahdat, Vahab
    Miller-Wilson, Lesley-Ann
    El Hoyek, Nancy
    Limburg, Paul J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S316 - S316